search
Back to results

Clinical Study - ES 900 - 2020-1

Primary Purpose

Cataract

Status
Not yet recruiting
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
EYESTAR 900
LENSTAR LS 900
Sponsored by
Haag-Streit AG
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Cataract focused on measuring Optical Biometry, Corneal Topography

Eligibility Criteria

35 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • voluntary participation
  • informed consent
  • 35 years of age or older

Exclusion Criteria:

  • ineligibility for cataract surgery for any reason, e.g., aphakia
  • Disqualifying pathologies:

    • keratoconus
    • corneal astigmatism of more than 3.5 D
    • history of recurrent inflammation or infection of the eye
  • Disqualifying corneal conditions:

    • comorbidities,
    • deformations,
    • lesions, or
    • scarring of the cornea
    • acute inflammation or infection of the eye
  • Disqualifying treatments:

    • previous refractive surgeries, including PRK and LASIK
    • previous corneal surgeries
    • previous corneal transplants
    • previous intraocular surgeries
  • Disqualifying outcomes:

    • failed IOL implantation into the capsular bag

Sites / Locations

  • Aravind Eye Hospitals

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Pre-Op

Post-Op

Arm Description

The experimental intervention is non-invasive optical imaging, in particular digital photography and optical coherence tomography, conducted with the investigational and comparator device, for the purpose of measuring dimensions of the eye.

The experimental intervention is non-invasive optical imaging, in particular digital photography and optical coherence tomography, conducted with the investigational and comparator device, for the purpose of measuring dimensions of the eye.

Outcomes

Primary Outcome Measures

Dense Cataract Performance
The primary outcome is the performance of the EYESTAR 900 in dense cataracts. Specifically, the highest grade of cataract at which complete measurements can reliably be performed and, consequently, the number of patients measured successfully.

Secondary Outcome Measures

Keratometry
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Axial Length
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
White-to-White Imaging
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Anterior Corneal Elevation
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Anterior Corneal Axial Curvature
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Anterior Corneal Tangential Curvature
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Posterior Corneal Elevation
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Posterior Corneal Axial Curvature
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Posterior Corneal Tangential Curvature
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Corneal Pachymetry
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Simulated Anterior Keratometry
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Simulated Posterior Keratometry
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.

Full Information

First Posted
March 22, 2022
Last Updated
June 22, 2022
Sponsor
Haag-Streit AG
Collaborators
Aravind Eye Hospitals, India
search

1. Study Identification

Unique Protocol Identification Number
NCT05304182
Brief Title
Clinical Study - ES 900 - 2020-1
Official Title
Clinical Study - ES 900 - 2020-1
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2022 (Anticipated)
Primary Completion Date
December 30, 2023 (Anticipated)
Study Completion Date
February 28, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Haag-Streit AG
Collaborators
Aravind Eye Hospitals, India

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
EYESTAR 900 is a device developed by Haag-Streit which utilises 3D OCT for quantitative measurements of the geometry of the entire eye, including ocular biometry and corneal topography. It is the most recent in a series of successful biometry devices by Haag-Streit (HS Pachymeter, Lenstar LS 900, LS 900 T-cone and LS 900 APS) and also allows for advanced corneal tomography examinations. The EYESTAR 900 is CE marked. These measurement results of this device are used for the planning of the medical treatment of patients. Depending on the application, the benefits of this device may include improved visual acuity (after cataract surgery), reduced risk of complications (after refractive surgery or implant of a phakic intraocular lens), early identification of pathological deformations of the cornea (keratoconus detection). The primary objective of this clinical trial is to assess the clinical performance of the investigational device in dense cataracts. To that end, for each measurand, the in-vivo repeatability will be quantified, as well as limits of agreement and the mean measurement deviation, with respect to the current gold standard device. As a secondary objective of the study, raw measurement data will be collected to allow for the improvement of existing algorithms, development of additional measurands and for retrospective analysis. No diseases are studied.
Detailed Description
The EYESTAR 900 is a non-contact device for measuring the human eye, consisting of a swept source OCT sub-unit (OCT: optical coherence tomography, a measurement method to acquire tomographic images by optical interferometry) and an imaging system sub-unit. The OCT sub-unit performs a three-dimensional measurement of all refractive ocular structures in the anterior eye segment (curvatures and locations of the anterior corneal surface, posterior corneal surface, the anterior crystalline lens surface, posterior crystalline lens surface), as well as a one-dimensional measurement of axial eye length. It also generates cross-sectional images of the anterior eye section and the central retina. The measurement is implemented by scanning the eye with a low-power near-infrared laser beam and measuring the light which is back-reflected to the device. The imaging system sub-unit is used to obtain photographic images of the eye. Based on these images, the keratometry (anterior corneal curvature of the steepest and flattest meridian), the white-to-white distance and the pupil diameter are measured. Additionally, these images can serve to document the locations of special landmarks on the eye, such as blood vessels. The imaging system sub-unit is based on conventional digital photography technology. Illumination for imaging is provided by infrared and white-light LEDs (light emitting diodes). Measurement of keratometry additionally requires measuring the distance to the eye using the OCT sub-unit. The EYESTAR 900 is designed as standalone-device with integrated PC (personal computer) and display for device operation, measurement acquisition and processing, and presentation of the measurement results. After a patient is placed in front of the device and the chin rest is adjusted, the device can perform the remaining positioning procedures and acquire the measurements in a fully automated manner. Position information is derived from the OCT and digital camera system sub-units. Both implemented measuring methods, optical coherence tomography (OCT), as well as digital photography are non-invasive, contactless methods. OCT uses a laser beam of λ=1060nm central wavelength and less than 2 mW optical power, which is focussed to a beam diameter of approximately 80µm at the anterior lens plane, and is continuously scanned in the lateral direction. Digital photography uses diffuse illumination of the eye by white-light LEDs (425nm ≤ λ ≤ 725nm) and infrared LEDs with central wavelength λ=850nm. All light sources emit levels that comply with ISO 15004-2 ("Ophthalmic Instruments - Fundamental requirements and test methods - Part 2: Light hazard protection"), under normal operating conditions as well as in case of a single fault condition. The main application of this device is to acquire biometric measurements of cataractous eyes which are used to calculate suitable intraocular lens power and dimension. The patient population must be capable of sitting up straight and keeping their head still and their eyes opened. They must be physically and mentally able to cooperate and mentally capable of following the examination. Patients must be at least 18 years old. The target device user is an ophthalmologist or a trained specialist. The investigational device EYESTAR 900 is developed and manufactured by HAAG-STREIT AG, Koeniz (Switzerland). For the duration of the examination (approximately 1-2 minutes), the patient is in contact with the device at following applied parts: the chin rest shell (Edistir RK451 G naturally coated with HAERATEX Aqua 2K-structural coater BW89 10K RAL 9005); the forehead rest band (Saxamid 126-N001 uncoated PA6 white FK 6659 PA); (depending on the subject's requirements) the patient handles (aluminium EN AW-6060 (AlMgSi 0.5) colourless anodized class 20 with sealing chemically polished and sandblasted). No other contact with body tissues or fluids takes place. No critical biocompatibility issues were identified.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract
Keywords
Optical Biometry, Corneal Topography

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
There are two identical arms in this study: pre-operative and post-operative. Every participant starts in the pre-operative arm and crosses over to the post-operative arm. During both arms, each study subject undergoes the experimental intervention and the control intervention. The study objective is to assess the clinical performance of the investigational device. This assessment is performed by a statistical analysis of the measurement results from the experimental intervention and the control intervention. The surgery is not a study intervention.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Pre-Op
Arm Type
Experimental
Arm Description
The experimental intervention is non-invasive optical imaging, in particular digital photography and optical coherence tomography, conducted with the investigational and comparator device, for the purpose of measuring dimensions of the eye.
Arm Title
Post-Op
Arm Type
Active Comparator
Arm Description
The experimental intervention is non-invasive optical imaging, in particular digital photography and optical coherence tomography, conducted with the investigational and comparator device, for the purpose of measuring dimensions of the eye.
Intervention Type
Device
Intervention Name(s)
EYESTAR 900
Other Intervention Name(s)
Optical Biometer
Intervention Description
The EYESTAR 900 is a device developed by Haag-Streit which utilises 3D OCT for quantitative measurements of the geometry of the entire eye, including ocular biometry and corneal topography. It is the most recent in a series of successful biometry devices by Haag-Streit (HS Pachymeter, Lenstar LS 900, LS 900 T-cone and LS 900 APS) and also allows for advanced corneal tomography examinations.
Intervention Type
Device
Intervention Name(s)
LENSTAR LS 900
Other Intervention Name(s)
Optical Biometer
Intervention Description
The LENSTAR LS 900 is a non-contact device for measurement of biometrical parameters of the eye, aimed to assist the calculation of intraocular lenses (IOLs) prior to intraocular lens implantation. The most common application is in preparation of cataract surgery. This device uses OLCR (optical low-coherence reflectometry), an interferometric method to measure intraocular axial distances. Furthermore, it uses digital photography of the anterior section of the eye to measure pupil size and location, as well as the white-to-white distance of the eye. The same photographic unit, in conjunction with a specific illumination pattern, is used to measure the corneal curvature - this measurement is known as 'keratometry', or, more specifically, 'automated keratometry'.
Primary Outcome Measure Information:
Title
Dense Cataract Performance
Description
The primary outcome is the performance of the EYESTAR 900 in dense cataracts. Specifically, the highest grade of cataract at which complete measurements can reliably be performed and, consequently, the number of patients measured successfully.
Time Frame
18 months
Secondary Outcome Measure Information:
Title
Keratometry
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
Axial Length
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
White-to-White Imaging
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
Anterior Corneal Elevation
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
Anterior Corneal Axial Curvature
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
Anterior Corneal Tangential Curvature
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
Posterior Corneal Elevation
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
Posterior Corneal Axial Curvature
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
Posterior Corneal Tangential Curvature
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
Corneal Pachymetry
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
Simulated Anterior Keratometry
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months
Title
Simulated Posterior Keratometry
Description
The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900.
Time Frame
18 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: voluntary participation informed consent 35 years of age or older Exclusion Criteria: ineligibility for cataract surgery for any reason, e.g., aphakia Disqualifying pathologies: keratoconus corneal astigmatism of more than 3.5 D history of recurrent inflammation or infection of the eye Disqualifying corneal conditions: comorbidities, deformations, lesions, or scarring of the cornea acute inflammation or infection of the eye Disqualifying treatments: previous refractive surgeries, including PRK and LASIK previous corneal surgeries previous corneal transplants previous intraocular surgeries Disqualifying outcomes: failed IOL implantation into the capsular bag
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rachit Bhandary
Phone
+91 40 24891250
Email
rachit@biomedixdevices.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Haripriya Aravind, MD
Organizational Affiliation
Aravind Eye Hospitals
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Thomas Beutler, Dipl. Ing.
Organizational Affiliation
Haag-Streit AG
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Julian Kool van Langenberghe, ing.
Organizational Affiliation
Haag-Streit AG
Official's Role
Study Chair
Facility Information:
Facility Name
Aravind Eye Hospitals
City
Chennai
State/Province
Tamil Nadu
ZIP/Postal Code
600077
Country
India
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nivetha K
Email
chennai.research@aravind.org
First Name & Middle Initial & Last Name & Degree
Haripriya Aravind, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Clinical Study - ES 900 - 2020-1

We'll reach out to this number within 24 hrs